![2-[4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid structure, CAS 516-50-7](/structures/210000/200036_1_516_50_7.png)
CAS Number516-50-7
Synonymstaurochenodeoxycholic acid; Deoxycholyltaurine; Tudcabil; Taurodeoxychloic Acid; [3H]-Deoxycholyltaurine; Taurodesoxycholic Acid; Deoxytaurocholic Acid; N-(3a,12a-Dihydroxy-5-cholan-24-oyl)taurine; 2-[[(3a,5,12)-3,12-Dihydroxy-24-oxocholan-24-yl]amino]ethanesulfonic Acid
Molecular FormulaC26H45NO6S
Molecular Weight499.71
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 516-50-7 |
| Catalog No. | 2A-1198152 |
| Chinese Name | 牛磺脱氧胆酸 |
| Synonyms | taurochenodeoxycholic acid; Deoxycholyltaurine; Tudcabil; Taurodeoxychloic Acid; [3H]-Deoxycholyltaurine; Taurodesoxycholic Acid; Deoxytaurocholic Acid; N-(3a,12a-Dihydroxy-5-cholan-24-oyl)taurine; 2-[[(3a,5,12)-3,12-Dihydroxy-24-oxocholan-24-yl]amino]ethanesulfonic Acid |
| Molecular Formula | C26H45NO6S |
| Molecular Weight | 499.71 |
| Application | Taurine, a bile acid, stabilizes mitochondrial membranes and reduces the formation of free radicals. Taurocholic acid inhibits apoptosis by blocking the calcium-mediated apoptotic pathway and caspase- |
| MDL Number | C26H45NO6S |
| SMILES | CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C |
| InChI | InChI=1S/C26H45NO6S/c1-16(4-9-24(30)27-12-13-34(31,32)33)20-7-8-21-19-6-5-17-14-18(28)10-11-25(17,2)22(19)15-23(29)26(20,21)3/h16-23,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16?,17-,18-,19+,20-,21+,22+,23+,25+,26-/m1/s1 |
| InChI Key | AWDRATDZQPNJFN-INWVEICNSA-N |
| MSDS | msds/200036_1_516_50_7.pdf |
| Transport Info | Product name: Tauodeoxycholic acid |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| (S)-methyl 3-(benzyloxycarbonylamino)-3-phenylpropanoate | 35909-92-3 | 2A-2198100 |
| 5-(((tert-butoxycarbonyl)amino)methyl)-2-chlorobenzoic acid | 165950-04-9 | 2A-2198109 |
| tert-butyl 3-((tert-butoxycarbonyl)oxy)azetidine-1-carboxylate | 1785763-73-6 | 2A-2198121 |
| (S)-2-(3-bromophenyl)propanoic acid | 1146411-14-4 | 2A-2198125 |
| (R)-MG132 | 1211877-36-9 | 2A-2198136 |
| 3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile | 2174011-55-1 | 2A-1198159 |
| 1-(tert-butoxycarbonyl)-3,3-difluoropiperidine-4-carboxylic acid | 1303972-81-7 | 2A-2198199 |
| Sacubitril-(2R,4R)-Isomer | 2259708-00-2 | 2A-1198209 |
| Trihexyl(tetradecyl)phosphoniumbis(trifluoromethanesulfonyl)amide | 460092-03-9 | 2A-2198230 |
| 1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-3-carboxylic acid | 1303974-65-3 | 2A-2198243 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA